Neuroprotective benefits of exercise for Parkinson’s

A growing body of evidence suggests that high levels of moderate to vigorous exercise may be a key interventional and neuroprotective therapy to slow progression of Parkinson’s disease (PD). Likewise, PD experts agree that physical activity is beneficial to PD patients at most stages of their disease, including at early diagnosis.

Botox® Therapy used successfully to treat dystonia, spasticity

Therapeutic Botulinum toxin, commonly referred to as “Botox therapy,” and other nerve blocks have been successfully used to treat neurological and musculoskeletal disorders such as dystonia, spasticity and cerebral palsy for the past 30+ years. Learn how Botox Therapy is used to manage spasms, stiffness and muscle pain associated with debilitating neurological disorders.

Medtronic deep brain stimulation therapy

10 tips for at home fall prevention

As people age, muscle degeneration occurs, and strength, and thus balance, becomes impaired. People who lead a sedentary lifestyle can lose about half their strength and about 40% of their muscle, which leads to a loss of balance as well.

Legislation advancing Parkinson’s research before committee

New legislation to create a national data collection system for Parkinson’s disease and other neurological disorders to support better research and services will be discussed during an upcoming meeting of the Capital Area Parkinson’s Society. Supported by the Parkinson’s Action Network, the H.R. 292 bill would allow for collection of data such as the geography of diagnoses, variances in gender, disease burden and changes in healthcare practices among patients to be used in a range of research initiatives and in evaluating and planning our nation’s health care needs,

Learning the facts about Parkinson’s Disease

Parkinson’s Disease Awareness Month is putting a spotlight on a neurological disorder affecting more than one million Americans and an estimated 7 to 10 million people worldwide.

Parkinson’s Disease (or PD) is a progressive disorder of the central nervous system that gradually affects patients’ movements through tremors, stiffness or slowing of movement. PD impacts nerve cells in a part of the brain called the substantia nigra impairing the cells’ ability to produce and deliver the neurotransmitter dopamine to other cells. In fact, by the time early Parkinson’s disease is diagnosed, it is estimated the person has lost 70 percent of the cells that produce dopamine.

Parkinson’s Patients Battle Sleep Disorders

We all know that adequate sleep plays an important role in our health and ability to function effectively each day. But what you may not know is that sleep problems such as insomnia, excessive daytime sleepiness and nightmares may be an early sign of Parkinson’s disease (PD), even before motor symptoms have begun (National Sleep Foundation).

© 2023 Neurology Solutions. All Rights Reserved.